OBJECTIVES: To evaluate the effect of a prior authorization (PA) requirement on medication persistence in the elderly following implementation of a step therapy program for proton-pump inhibitors (PPI) in the Military Health System. METHODS: Our study population comprised 33,226 TRICARE benefi ciaries 65 years old with a PPI prescription between October 24, 2007 and January 31, 2008. The PA required patients without a PPI prescription in the last 180 days to receive a trial of the preferred product (omeprazole or esomeprazole) before receiving another PPI. The study cohort (n 15,294) included patients affected by the PA requirement; the reference cohort (n 17,932) was not affected because patients received an initial fi ll for the preferred product. Medication persistence was measured as 1) proportion of days covered (PDC) with persistence defi ned as 80% of days covered, and (2) time to fi rst gap 30 days following initiation. Differences in medication persistence between cohorts were detected using logistic regression and a proportional hazards model, adjusted for age, gender, and type of pharmacy (community vs. mail order). RESULTS: In the 6 months following initiation of PPI treatment, 46% of study subjects were not persistent (PDC 80%), while 77% experienced a gap in treatment 30 days. Exposure to the PA requirement decreased the odds of being persistent with treatment at 6 months by 39% (OR 0.61; 95% CI 0.58¨C0.64) and increased the risk of experiencing a 30-day gap in treatment by 17% (HR 1.17; 95% CI 1.14¨C1.20). CONCLU-SIONS: The prior authorization program was associated with lower rates of medication persistence. Further study should evaluate whether the reduction in persistence had an effect on patient clinical outcomes.
PGI13 RESPONSIVENESS TO CHANGE AND CLINICALLY RELEVANT IMPROVEMENTS OF THE SF-36 QUESTIONNAIRE IN SWEDISH PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE
Wahlqvist P q , Medin J, Rydén A P P AstraZeneca R&D Mölndal, Mölndal, Sweden OBJECTIVES: To assess responsiveness to change of the Short Form-36 (SF-36) questionnaire in patients with gastroesophageal refl ux disease (GERD), and whether clinically relevant improvements in symptoms correlate with improvements in the SF-36. METHODS: The SF-36 (acute version, 1-week recall, score: 0-100) was used in a methodological study in 205 Swedish GERD patients before and after 4 weeks' proton pump inhibitor (PPI) treatment. After treatment, patients completed a 7-graded Overall Treatment Evaluation (OTE) questionnaire with regard to GERD symptoms, from which three main OTE response groups were identifi ed (no or small improvement, moderate improvement, large improvement). Responsiveness was assessed by calculating effect sizes (ES) for all patients and by OTE response group. Clinically relevant improvements were assessed by comparing SF-36 changes to Swedish population norm values and by investigating SF-36 changes by OTE response group. RESULTS: The mean overall before-after PPI treatment change for the Physical Component (PC) and Mental Component (MC) scores of the SF-36 were 4.6 and 4.4, respectively, and ranged from 5.1 to 18.9 for the eight individual SF-36 dimensions (all p 0.001). However, SF-36 scores after treatment were similar to Swedish population norm values only in those who reported a large improvement in treatment effect on symptoms, according to the OTE. Mean OTE changes and ES consistently increased with degree of improvement for all eight SF-36 dimensions and the PC and MC scores, demonstrating an association between clinically relevant improvements in symptoms and improvements in SF-36. Overall, ES were moderate to high in patients experiencing a large improvement according to the OTE. CONCLUSIONS: Successful GERD treatment, as reported by patients, resulted in both statistically signifi cant and clinically relevant improvements in SF-36 scores. The SF-36 was found to be responsive to change. Given the methodology used, results should be regarded as applicable only in a GERD population.
PGI14

RESPONSIVENESS TO CHANGE AND CONSTRUCT VALIDITY OF THE WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT QUESTIONNAIRE FOR GASTROESOPHAGEAL REFLUX DISEASE (WPAI : GERD) IN SWEDISH PATIENTS
Wahlqvist P q 1 , Medin J 1 , Karlsson M 1 , Reilly MC 2 1 AstraZeneca R&D Mölndal, Mölndal, Sweden, 2 Margaret Reilly Associates, Inc, New York, NY, USA OBJECTIVES: To assess responsiveness to change and construct validity of the Work Productivity and Activity Impairment questionnaire for gastroesophageal refl ux disease (WPAI : GERD), a GERD-specifi c adaptation of the Specifi c Health Problem version of the WPAI. METHODS: The WPAI : GERD measures GERD-specifi c work absenteeism, presenteeism (reduced productivity while at work) and impairment in regular daily activities other than work during the preceding week. It was completed by 205 employed Swedish patients before and after 4 weeks' proton pump inhibitor treatment for GERD. Responsiveness was assessed by calculating effect sizes (ES) for all patients and by response group according to a 7-graded Overall Treatment Evaluation (OTE) questionnaire. Construct validity was assessed by investigating the relationship between WPAI measures and symptoms, as well as health-related quality of life (HRQL). RESULTS: Absenteeism was not included in the analyses due to very high variability in the results and the relatively low mean before-after treatment change (0.4 hours; 95% CI: 2.4, 3.1). The mean overall before-after treatment change in percent reduced productivity was 15.3% for presenteeism (from 25.5% to 10.2%; p 0.001) and 18.3% for impairment in daily activities (from 31.5% to 13.2%; p 0.001). ES were moderate for the whole study population (presenteeism: 0.67, activity impairment: 0.79) and were large in patients experiencing a large improvement according to the OTE (presenteeism: 0.98, activity impairment: 1.22). Cross-sectional Pearson correlation coeffi cients between WPAI variables and symptoms (range: 0.06-0.67), as well as HRQL (range: 0.19-0.79) supported cross-sectional construct validity of the WPAI : GERD. Corresponding change score correlations (range for symptoms: 0.17-0.56, range for HRQL: 0.15-0.61) and a descriptive analysis of change in productivity by change in heartburn severity also supported longitudinal construct validity. CONCLUSIONS: Results indicated that the WPAI : GERD measures of presenteeism and activity impairment are responsive to change. Cross-sectional, as well as longitudinal, construct validity of the measures was confi rmed.
PGI15 ADULT CANADIANS SUFFERING FROM ACID RELATED DISEASES: PATIENT REPORTED ATTITUDES, PERCEPTIONS, AND IMPACT ON THEIR LIFE
Beamer B, Ciobanu A, Liovas A AstraZeneca, Mississauga, ON, Canada OBJECTIVES: To understand patient attitudes and perceptions towards acid related diseases (ARD). Furthermore to reveal the degree to which ARD affect patient lives, and uncover their level of satisfaction with prescription medicines. METHODS: On line Canadians 18 years were solicited by email by a national interactive research organization. Those who reported a diagnosis of stomach ulcer, duodenal ulcer, heartburn, acid refl ux/GERD/refl ux esophagitis, Irritable Bowel Syndrome (IBS) or dyspepsia/stomach pain, and who have taken prescription medicines for at least one month were directed to an on line interactive English or French survey instrument from July-August 2007. RESULTS: A total of 1033 ARD patients responded(East 106,Quebec 260,Ontario 364,West 303). The following conditions were reported: stomach ulcer (64); duodenal ulcer (20); heartburn (219); Acid Refl ux/GERD (647); Dyspepsia (80); IBS (7). A 2-year average delay was reported before talking with their physicians about their symptoms. They experience numerous troublesome symptoms prior to taking medication including heartburn, acidic taste, stomach pain, indigestion, chest pain, and sleeping problems. Prior to seeking care and medication for these symptoms, four in ten reported they felt tired, worn out and were unable to sleep. Nearly one in ten report missing work. Patients make changes to their diet, social, work and daily activities to compensate for their conditions. 80% experienced at least one somewhat severe or severe symptom prior to treatment, while only 21% did post treatment. 45% of patients were referred to a specialist with an average wait time over 12 weeks. Of those referred, 47% underwent an endoscopy. CONCLUSIONS: Canadians suffering from ARD experience numerous troublesome symptoms that negatively impact their quality of life, including missing work, yet on average they wait two years before seeking help from their physician. Nearly one half are referred to specialists and about half of these receive an endoscopy.
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PGI16 FACTORS INFLUENCING GASTROESOPHAGEAL REFLUX DISEASE OUTPATIENTS' CHOICES TO ACCESS DIFFERENT TIERS OF MEDICAL FACILITIES: THE PRELIMINARY STUDY OF A DISCRETE CHOICE EXPERIMENT
Tseng JH g J 1 , Chen LC 1 , Kuo C 2 , Lu C 1 1 Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, 2 Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan OBJECTIVES: Taiwan's single payer national health insurance system provides generous coverage and patients' full freedom to access different tiers of medical facilities. Government's attempt to divert outpatient care utilisation into primary care by largely increasing co-payment only showed limited effects. To determine the relative importance of factors (attributes) associated with patients' choices of accessing different tiers of medical facilities, we conducted a qualitative study on outpatients with gastroesophageal refl ux disease (GERD), who generally do not need aggressive treatment. METHODS: Focus groups were conducted on outpatients with GERD from different tiers of medical facilities in Southern Taiwan. RESULTS: Seven focus groups were held in medical centers (2), regional hospitals (2), physician clinics (2), and local community (1), recruiting 35 participants from cities and an off-shore island. Reputation of doctors and scale of medical facilities are the highest priorities and unanimous considerations of all participants. Distance (transportation convenience) is also an important attribute for accessing medical care. Information sources for making decision includes consultation with relatives and friends, searching internet information, or rank of hospitals and doctors from media. Participants generally thought the current out-of-pocket payment (OPP) is expensive, especially when accessing medical centers, but they still preferred and felt worthy to visit higher tiers of medical facilities due to
